Abstract: Monoclonal antibodies generated by modern biotechnology are useful as therapeutic agents for many kinds of diseases. Laboratory mice are a ready source for generating high-affinity and specificity monoclonal antibodies. However, the limitation of rodent antibodies as therapeutic molecules forces many biotechnology groups to explore new technologies to generate safer and more efficacious human antibodies, which includes the construction of transgenic mice encoding human sequences. We report here that human umbilical cord blood cells, containing some stem cells, were introduced into mouse fetal peritoneal cavities to generate humanized chimeric mice. The expressions of human immunoglobulin genes were detected in peripheral blood of adult chimeric mice. Our study demonstrates successful production of humanized chimeric mice by fetal peritoneal cavity injection with human umbilical cord blood cells. The chimeras are likely to be a valuable tool for obtaining therapeutic human antibodies.
INTRODUCTION
Monoclonal antibodies (mAbs) are an important class of therapeutic compounds used to treat diverse diseases including cancer, inflammation, autoimmune diseases, infections and cardiac diseases [1] [2] [3] . Until the early 1990s, however, most products were mouse mAbs, which have limited efficacy and may result in immune reactions [4] . The limitations of murine mAbs become the driving force for researchers to generate partially or fully human antibodies. Firstly, researchers re-engineered the mouse antibodies in vitro to replace framework amino acid residues with corresponding human ones [5] [6] [7] . Subsequently human mAbs were generated from human B cells [8, 9] . However, these applications are limited by the low affinity and low specificity of the synthetic mAbs [10] , or the scarcity of obtaining the desired human B cells and difficulty in achieving immortalization [11] . Currently, a number of research groups are exploring the use of transgenic mice expressing human immunoglobulin repertoires to produce a wide diversity of high-affinity and lowimmunogenicity human antibodies [12] [13] [14] [15] [1, 13, 14, 17] . All of these engineered mice with the human humoral immune system could be used to generate a large and diverse repertoire of high-affinity human antibodies. However, the genes of the human immunoglobulin chain, especially the heavy chain, are too long to be easily transplanted. It is even more difficult to transplant all of the human immunoglobulin genes to mice.
To achieve a more complete human immune system in chimeric mice, we applied another methodology to produce humanized chimeric mice: transplanting human cord blood cells into the mouse fetal peritoneal cavity. The human immunoglobulin genes and their products were detected in peripheral blood of chimeric mice, and no graft-versus-host disease (GVHD) was observed, suggesting that fetal transplantation of human cord blood cells is a viable technique for generating humanized chimeras to produce therapeutic human antibodies.
MATERIALS AND METHODS

Animals
Mice C57BL/6 and C57BL/6 x CD-1 used for this study were housed and treated according to the procedures approved by the Institutional Animal Care and Research Committee and the National Research Council Guide for Care and Use of Laboratory Animals.
Human Umbilical Cord Blood Cells Isolation and Transplantation
Human Umbilical Cord Blood Cells Collection and Isolation
Human umbilical cord blood was obtained from consenting mothers undergoing cesarean section. The cord blood collections (final volume higher than 50 ml) were centrifugation and the supernatants discarded. The sediments were washed three times with PBS, and then re-suspended in 200 μl of PBS.
Transplantation
The suspension of human umbilical cord blood cells was injected into the peritoneal cavity of all fetuses from pregnant mice on days 8 to 12 according to the surgical procedure described by Rice et al. [18] . Pregnant mothers were anesthetized, and the uterus was exposed following a single vertical abdominal incision. 10 μl of cell suspension obtained above were inoculated into each individual fetal peritoneal cavity using a sterile Hamilton syringe. The uterus was then carefully returned to the abdominal cavity, and then both peritoneal wall and skin were sutured.
PCR Amplifications
The genomic DNA of peripheral blood, including chimeric mouse blood, artificial human-mouse blood mixture, human blood and mouse blood, was isolated using the DNA Extraction Kit for Blood (Sbsgene, Shanghai, China). The DNA from human blood was used as a positive control, while that from mouse blood was used as a negative control. The whole DNA of artificial human-mouse blood mixture (human blood: mouse blood = 1:1000) was used to optimize the PCR procedure. One primer pair was designed, IgGLKf-r (forward primer, 5 -GTG GCT GCA CCA TCT GTC TTC ATC-3'; reverse primer, 5'-CTA ACA CTC TCC CCT GTT-3') for human immunoglobulin kappa light chain. The PCR reaction for IgGLKf-r was performed in 50 μl final volume containing 0.5 l of each 20 M primer, 5 l of 10x PCR Buffer, 1 l of 10 mM dNTP mix, 0.7 l of super Taq DNA polymerase (5 U/ l), and 1 l of the DNA template mentioned above. The thermal cycle was as follows: 94°C for 5 min, 40 cycles of 60 s at 94°C, 60 s at 55°C, 60 s at 72°C, and 72°C for 7 min; finally holding at 4°C.
Ten microliters of the PCR products were characterized by 1.5% agarose gels electrophoresis. Images were obtained by Gel Doc XR (Bio-Rad, Hercules, CA, USA).
Dot Blots
Preparation of First Antibody
Mouse anti-human IgG (gamma chain specific, Southern Biotech, Birmingham, AL, USA) was conjugated with EZ-Link Activated Peroxidase according to the manufacturer's instructions (Thermo Fisher Scientific, Waltham, MA, USA), except 0.1 mg Anti-Human IgG was dissolved and dialyzed into Conjugation Buffer (0.1 M NaHCO 3 , 0.9% NaCl, pH 9.5) by centri-ultrafiltration 3 times with till 100 μl of Conjugation Buffer.
Dot Blots
The lysates of whole blood cells were prepared by ultrasonication. Protein concentrations or serum samples were assayed by the BCA Protein Assay Kit (Sangon, Shanghai, China) using BSA as a standard. Quantities of cell extract were blotted onto nitrocellulose membrane (Flow-Plus Nitrocellulose, NC). After blocking in 3% BSA/sodium phosphate buffer (10 mM, pH=7.2, containing 0.9%NaCl) for 1 h, the membranes were incubated in mouse anti-humanIgG-HRP (1:16) for 35 min. After washing 3 times with sodium phosphate buffer, the immunoreactive dots were visualized by chemiluminescence (DAB solution).
Immunocytochemistry
Immunohistochemistry was performed with the same antibody used for the dot blots. Blood smears were prepared and fixed in methanol at room temperature for 5 min. After washing three times with PBS, the fixed blood cells were blocked in 10% normal goat serum for 10 min and then incubated overnight at 4°C with mouse anti-human IgG (gamma chain specific, Southern Biotech) (diluted 1:10). The next steps of the immunofluorescence staining were performed in a humid, dark chamber. After extensive washing in PBS, the slides were incubated at 37°C for 30 min with fluorescein isothiocyanate (FITC)-conjugated goat anti-mouse IgG (dilution 1:100; SinoAmerican Biotechnology Co., Shanghai, China), then incubated at 37°C for 20 min with DAPI (dilution 1:10,000) after washing with PBS. The blood smears were then overlaid with a coverslip using mounting medium (glycerol diluted 3:1 in PBS). Images were obtained by a Nikon Eclipse E600 microscope and a Nikon Dxm 1200 digital camera, using fluorescein optics for FITC and ultraviolet optics for DAPI.
RESULTS
Generation of Humanized Chimeric Mice
Umbilical cord blood is an accessible source for obtaining stem cells, which are pluripotent cells capable of forming many different cell types [19] . Umbilical cord blood stem cells have been used for stem cell transplantation to reconstitute blood cell formation (the hematopoietic system) in patients. We wondered whether transplantation of mice with human umbilical cord blood cells could result in systemic reconstitution of an immune system with humanderived cells.
We first collected cord blood cells from human umbilical cord blood, and then injected the donor cells directly into the peritoneal cavity of fetuses at 8-12 days of gestation. The process is shown in Figure 1 . Of the 25 fetuses that received human cord blood cells, 4 completed gestation and were born alive. Chimerism was detected in 3 of the 4 mice born alive. No evidence of life-threatening GVHD was noticed in these animals. All of them survived for >7 months. 
Expression of Human Immunoglobulin Proteins in Peripheral Blood of Chimeric Mice
By performing PCR using genomic DNA of blood cells from the chimeras as a template, immunoglobulin kappa light chain gene was detected in samples from chimeric mice (Figure 2) , suggesting the human immunoglobulin genes were in present the chimeric mice. Using the IgGLKf-r primer pair, the human immunoglobulin kappa light chain gene (HIgGL ) was detected in DNA samples from blood cells in chimeric mice (lane 3 and 4) . In the procedures, the positive controls (lane 1: using DNA from human blood as a template, and lane 2: using DNA from mixture of 1% human blood and 99% mouse blood as a template) and negative control (lane 5) were also performed.
To detect whether there was expression of human IgG proteins in peripheral blood of adult chimeric mice, we performed Dot blots using total proteins from peripheral blood cells and proteins in serum as samples. The results showed that human IgG proteins were expressed only in blood cells, not in blood serum of chimeric mice (Figure 3) . Immunocytochemistry also showed that human IgG proteins were present at the surface of blood cells and could be detected in all chimeras even at >7 months (Figure 4) . These results indicate that the permissive environment of preimmune fetal mice provides suitable conditions for the engraftment, expansion and reconstitution of a human immune system of human cord blood cells in mice. 
DISCUSSION
Human cord blood cells contain stem cells, which may re-encode and modify their differentiative patterns through environmental conditioning. Traggial, E. et al. injected CD34+ human cord blood cells into the liver of newborn mutant mouse strain that lacked B, T, and NK cells [9] . The transplanted mice were shown to produce a functional human adaptive immune system in vivo. However, the immune system was immature [9] . The reason may have been that the mouse they used for transplantation was already born. Other research teams have performed in utero transplantation procedures to construct chimeras [20] [21] [22] . This technique may be better than newborn-mouse transplantation procedures to produce a humanized immuno-competent mouse. In contrast to adult recipients, the immune system of fetal recipients is still largely immuno-naïve and allows not only xenotransplantation but also the creation of tolerance [23] . Furthermore, xeno-transplantation into fetal recipients permits engrafting, homing, proliferation and differentiation of human stem cells under the environmental condition in fetuses [23] . In our strategy, human cord blood cells were transplanted into mice fetuses at 8-12 days of gestation, when these fetuses were still at the pre-immune stage of development [20, 21] . This creates conditions under which stem cells may reconstitute a human immune system.
In mammals, 75% of serum immunoglobulin is IgG, comprising two gamma heavy chains and two kappa light chains [24] . IgG has four subclasses, among which, IgG1 accounts for 66%. Thus, to detect the existence of human immunoglobulin genes and their expression in chimeric hematopoietic system, primers for human immunoglobulin kappa light chain were designed, and a human IgG specific antibody was used. PCR analysis showed that the human immunoglobulin genes were in the genome of blood cells from the chimeric mice. Interestingly, dot blot analysis indicated that the expression of human IgG protein was detected only in lysate of blood cells but not in blood serum. Immunocytochemistry analysis demonstrated that human IgG proteins were localized at surface of blood cells. This connection between the human IgG proteins and the surface of the mouse blood cells may not affect the function of the immune system in chimeric mice, for no GVHD was observed in any of the chimeras and they all were healthy at >7 months. Moreover, in chimeras at >7 months of age, the human IgG proteins were still expressed, suggesting our strategy may obtain a long-term and stable humanized immune system. Whether this technique can produce an ideal chimera strain that generates a large and diverse repertoire of high-affinity antibodies by natural recombination and affinity maturation processes using embryos of immunodeficient mice as the transplanted object, remains to be investigated.
